Compare · EW vs NTIC
EW vs NTIC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Northern Technologies International Corporation (NTIC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while NTIC operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $48.52B, about 637.3x NTIC ($76.1M).
- Over the past year, EW is up 11.4% and NTIC is up 9.1% - EW leads by 2.3 points.
- EW has been more active in the news (5 items in the past 4 weeks vs 4 for NTIC).
- EW has more recent analyst coverage (25 ratings vs 0 for NTIC).
- Company
- Edwards Lifesciences Corporation
- Northern Technologies International Corporation
- Price
- $84.16+5.54%
- $8.15+0.62%
- Market cap
- $48.52B
- $76.1M
- 1M return
- +1.83%
- -4.23%
- 1Y return
- +11.37%
- +9.10%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 4
- Recent ratings
- 25
- 0
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Northern Technologies International Corporation
Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of biobased and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.
Latest EW
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
- SEC Form 4 filed by Ullem Scott B.
- SEC Form 4 filed by Lippis Daniel J.
- SEC Form 4 filed by Bobo Donald E Jr
- Edwards Lifesciences upgraded by Wolfe Research with a new price target
- Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
- Amendment: SEC Form SCHEDULE 13G/A filed by Edwards Lifesciences Corporation
- SEC Form DEFA14A filed by Edwards Lifesciences Corporation
Latest NTIC
- Northern Technologies International Corporation filed SEC Form 8-K: Other Events
- SEC Form 10-Q filed by Northern Technologies International Corporation
- Northern Technologies International Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Northern Technologies International Corporation Reports Financial Results for Second Quarter Fiscal 2026
- Northern Technologies International Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Northern Technologies International Corporation Announces Quarterly Cash Dividend
- SEC Form 10-Q filed by Northern Technologies International Corporation
- Northern Technologies International Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Northern Technologies International Corporation Reports Financial Results for First Quarter Fiscal 2026
- Northern Technologies International Corporation to Announce Fiscal 2026 First-Quarter Financial Results and Host Conference Call